MDMA/MDA Screen with Confirmation, Urine

Overview

  • EPIC Code:
  • LAB2854
  • Soft Test Code:
  • MDMA
  • Send Out Test Code:
  • 10690MSOT
Alternate Names
  • Ecstacy
  • Ecstasy
  • Methylenedioxymethamphetamine
  • XTC
Clinical Significance

This test is designed to detect the use of the stimulant/ hallucinogen methylenedioxymethamphetamine (MDMA, XTC, Ecstasy) and its metabolite methylenedioxyamphetamine (MDA


Specimen Collection & Preparation

Specimen Requirements

20.0 mL Urine in a Plastic Container


Transport And Storage

14 days Ambient
14 days Refrigerated
30 days Frozen


Collection Instructions

 


Minimum Volume

5.0 mL Urine


Neonatal Volume

Clinical Interpretation

Reference Range:

Negative

Cutoff; 500 ng/mL


Methodology:
  • Immunoassay (IA)
Clinical Significance

This test is designed to detect the use of the stimulant/ hallucinogen methylenedioxymethamphetamine (MDMA, XTC, Ecstasy) and its metabolite methylenedioxyamphetamine (MDA


Production Schedule

Sites Performed
  • Quest - Chantilly
Days Performed
Tuesday
Wednesday
Thursday
Friday
Saturday
Departments
  • Sendouts - Clinical

Coding & Compliance

CDM

00913333


CPT Coding

80101 If Screen is positive, confirmation will be performed at an additional charge 82145